Tm BioScience Shareholders OK Luminex's Acquisition Bid | GenomeWeb
NEW YORK (GenomeWeb News) — Shareholders and option holders in Tm Bioscience have approved a plan by Luminex to buy the Canadian company, Tm said today.
The company said the acquisition now will go before an Ontario Superior Court Justice for review on Feb. 27. If the court approves the deal it should close the following day, Tm said.
The acquisition was originally announced last December.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.